Literature DB >> 12774135

Rising birth prevalence of gastroschisis.

Matthew Laughon1, Robert Meyer, Carl Bose, Alison Wall, Eduardo Otero, Ann Heerens, Reese Clark.   

Abstract

OBJECTIVE: Gastroschisis is a congenital anomaly that has been reported to be increasing in frequency. The objective of this study was to determine the birth prevalence of gastroschisis using two large databases. STUDY
DESIGN: We reviewed data from a statewide database and a national database from a neonatal health care provider, abstracting cases of gastroschisis.
RESULTS: In North Carolina, the birth prevalence of gastroschisis increased from 1.96 per 10,000 births in 1997 to 4.49 per 10,000 births in 2000 (p=0.0007). The overall increase was almost entirely because of the increase in infants born to mothers less than 20 years old. Among infants receiving care from the national neonatal provider, the prevalence of gastroschisis increased from 2.9 per 1000 patients in 1997 to five per 1000 patients in 2001 (p=0.044).
CONCLUSION: The birth prevalence of gastroschisis is increasing in North Carolina, and this trend may be occurring nationally. The rapid change in the birth prevalence in the subset of population most at risk for gastroschisis implicates environmental or pharmacologic teratogens rather than changing population characteristics as a causal factor in the development of gastroschisis.

Entities:  

Mesh:

Year:  2003        PMID: 12774135     DOI: 10.1038/sj.jp.7210896

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  23 in total

Review 1.  Clinical risk factors for gastroschisis and omphalocele in humans: a review of the literature.

Authors:  Polina Frolov; Jasem Alali; Michael D Klein
Journal:  Pediatr Surg Int       Date:  2010-08-31       Impact factor: 1.827

Review 2.  Gastroschisis: an update.

Authors:  Andrew J A Holland; Karen Walker; Nadia Badawi
Journal:  Pediatr Surg Int       Date:  2010-08-05       Impact factor: 1.827

3.  Evaluation of Early Onset Sepsis, Complete Blood Count, and Antibiotic Use in Gastroschisis.

Authors:  Sadie L Williams; Matthew Leonard; Eric S Hall; Jose Perez; Jacqueline Wessel; Paul S Kingma
Journal:  Am J Perinatol       Date:  2017-10-30       Impact factor: 1.862

4.  Trends in incidence and outcomes of gastroschisis in the United States: analysis of the national inpatient sample 2010-2014.

Authors:  Parth Bhatt; Anusha Lekshminarayanan; Keyur Donda; Fredrick Dapaah-Siakwan; Badal Thakkar; Sumesh Parat; Shilpi Chabra; Zeenia Billimoria
Journal:  Pediatr Surg Int       Date:  2018-07-28       Impact factor: 1.827

5.  Maternal residential atrazine exposure and gastroschisis by maternal age.

Authors:  A J Agopian; Peter H Langlois; Yi Cai; Mark A Canfield; Philip J Lupo
Journal:  Matern Child Health J       Date:  2013-12

6.  Outcomes in infants with prenatally diagnosed gastroschisis and planned preterm delivery.

Authors:  Carmen Mesas Burgos; Anna Svenningsson; Jenny Hammarqvist Vejde; Tina Granholm; Peter Conner
Journal:  Pediatr Surg Int       Date:  2015-09-23       Impact factor: 1.827

7.  Spatial analysis of gastroschisis in the National Birth Defects Prevention Study.

Authors:  Mahsa M Yazdy; Martha M Werler; Marcia L Feldkamp; Gary M Shaw; Bridget S Mosley; Veronica M Vieira
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-04-06

8.  Maternal Antibodies to Herpes Virus Antigens and Risk of Gastroschisis in Offspring.

Authors:  Martha M Werler; Samantha E Parker; Klaus Hedman; Mika Gissler; Annukka Ritvanen; Heljä-Marja Surcel
Journal:  Am J Epidemiol       Date:  2016-11-17       Impact factor: 4.897

9.  Scheduled preterm delivery for gastroschisis improves postoperative outcome.

Authors:  Thomas Gelas; Daniela Gorduza; Simone Devonec; Pascal Gaucherand; Esther Downham; Olivier Claris; Rémi Dubois
Journal:  Pediatr Surg Int       Date:  2008-07-31       Impact factor: 1.827

10.  Does staged closure have a worse prognosis in gastroschisis?

Authors:  Augusto Frederico Schmidt; Anderson Gonçalves; Joaquim Murray Bustorff-Silva; Antônio Gonçalves Oliveira Filho; Sergio Tadeu Marba; Lourenco Sbragia
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.